Peptide Research

hCG: What It Does in Men and Why It Is Not a Peptide

hCG is a glycoprotein hormone, not a peptide — and it is the one HPG-axis compound that works when the pituitary does not.

Peptide Library Editorial · July 19, 2026 · 3 min read

hCG: What It Does in Men and Why It Is Not a Peptide — Peptide Library research guide

hCG is not a peptide. Human chorionic gonadotropin is a glycoprotein hormone — two subunits with substantial carbohydrate attachment, far larger and more complex than anything in the peptide category. It is grouped with peptides commercially, not chemically.

It is also the most mechanistically distinct compound used on the male hormonal axis.

What it does

hCG shares its alpha subunit with LH, FSH and TSH, and its beta subunit determines what it binds. In practice hCG binds the LH receptor and acts as an LH mimetic.

That means it acts directly on the testes, bypassing both the hypothalamus and the pituitary entirely.

Compound

Acts on

Requires a working pituitary?

Kisspeptin-10

Above the hypothalamus

Yes

Gonadorelin (GnRH)

Pituitary

Yes

Enclomiphene

Hypothalamus / pituitary feedback

Yes

hCG

Testes directly

No

Exogenous testosterone

Replaces the output

No — and suppresses the axis

That last column is the whole clinical distinction. Every other upstream compound needs a functioning pituitary to relay the signal. hCG does not — which is exactly why it is the agent used when the pituitary is the problem, or when it has been suppressed.

Established clinical uses

hCG is an approved drug with genuine indications, which separates it from most compounds discussed on this site.

  • Hypogonadotropic hypogonadism — where the pituitary signal is absent or insufficient.

  • Fertility induction in men, often combined with FSH to restore spermatogenesis.

  • Ovulation induction in assisted reproduction.

  • Cryptorchidism in some paediatric contexts.

  • Preserving testicular function alongside testosterone therapy, which is a common off-label use with a clear rationale.

A 2026 review examined the therapeutic benefits of gonadotropins in male hypogonadotropic hypogonadism with a focus on spermatogenesis and fertility, and a 2026 multicentre randomised controlled trial examined gonadotropin therapy in idiopathic hypogonadal non-obstructive azoospermia.

Why it is used with testosterone therapy

Exogenous testosterone suppresses LH and FSH through negative feedback. Without LH, the testes stop producing testosterone locally and stop supporting spermatogenesis — which is why testosterone therapy commonly causes testicular atrophy and impaired fertility.

hCG substitutes for the missing LH signal. It maintains intratesticular testosterone and testicular volume during therapy. The rationale is sound and widely applied, and it does not make the combination self-manageable — it is a prescribing decision requiring monitoring.

Intratesticular testosterone is not measured by a standard blood test. Serum testosterone can look entirely adequate on therapy while intratesticular levels — the ones that matter for sperm production — are profoundly suppressed. This is a specific reason self-directed protocols in this area go wrong invisibly.

The hCG diet

hCG has a long association with a very-low-calorie diet protocol, and this is worth addressing directly.

The weight loss in that protocol comes from the calorie restriction. Controlled trials comparing hCG against placebo alongside the same restricted diet have not found hCG to add benefit. FDA has stated that hCG is not approved for weight loss and has acted against products marketed that way.

Practical considerations

Detail

Route

Subcutaneous or intramuscular injection

Frequency

Typically several times weekly; regimen depends on indication

Monitoring

Testosterone, oestradiol, semen analysis where fertility is the goal

Oestradiol

Can rise — hCG stimulates testicular aromatase activity

Desensitisation

Possible with high sustained dosing

Reconstitution

Supplied lyophilised; see the reconstitution guide

The oestradiol point is the one most often missed. Stimulating the testes raises testosterone and aromatisation together, so oestradiol frequently rises more than expected — which is a reason for bloodwork rather than assumption.

See the peptides for testosterone guide for the full axis, the gonadorelin guide for the pituitary-level alternative, and the reconstitution guide for handling.

Research and educational use only. Peptide Library is an independent research and comparison platform and does not sell peptides. Nothing here is medical advice, dosing guidance, or a recommendation to administer any substance to a person or an animal. Consult a licensed clinician for anything concerning human health.

Sources

  1. 1. Therapeutic benefits of gonadotropins in male hypogonadotropic hypogonadism: a focus on spermatogenesis and fertility — Reproduction and Fertility (2026) Source PubMed
  2. 2. Gonadotropin therapy in idiopathic hypogonadal non-obstructive azoospermia (APHRODITE Groups 3-4): a multicenter randomized controlled trial — Frontiers in Reproductive Health (2026) Source PubMed

Author

Peptide Library Editorial

Editorial content from Peptide Library. Research and educational use only. Not medical advice.

Related tools

Research smarter with Peptide Library.

Compare peptides, review vendor data, and use research calculators in one place.

Explore the Library

Research and educational use only. Not medical advice. Peptide Library does not sell peptides.